The Proteome Universe

Talk Precision Medicine

Proteomics big data can help solve decision-making problems related to the diagnosis and treatment of prostate cancer.

03 / 01 / 2020 | Tiannan Guo

The most common cancer in men is often over-diagnosed and over-treated. The scientists at Westlake University have developed a mass spectrometry-based approach to fully characterize the proteome of tumor tissues, all in a single data record. Machine learning analysis can then clearly stratify cancer patients by survival probability using a protocol that can potentially be applied to various other diseases.

  • “Over the past 7 years, we have developed a protocol called PCT SWATH [acquisition]—pressure cycling technology coupled with SWATH [acquisition] mass spectrometry—which enables us to immortalize clinical samples.”

    Tiannan Guo

Tiannan Guo, MD, PhD

Principal Investigator
Guomics Laboratory for Proteomic Big Data, Westlake University

Director
iMarker lab, Westlake Laboratory

View profile